| Literature DB >> 33856518 |
Renato Cuocolo1,2, Massimo Imbriaco3.
Abstract
KEY POINTS: • Interest in radiomics and machine learning is steadily increasing and is reflected both in research output and number of commercially available solutions.• Currently available commercial products using machine learning are often supported by limited evidence of clinical usefulness and studies are often of low methodological quality.• Ethical and regulatory issues remain open and hinder implementation of machine learning software packages in daily clinical practice.Entities:
Mesh:
Year: 2021 PMID: 33856518 DOI: 10.1007/s00330-021-07895-w
Source DB: PubMed Journal: Eur Radiol ISSN: 0938-7994 Impact factor: 5.315